申请人:STANGELAND Eric L.
公开号:US20120088799A1
公开(公告)日:2012-04-12
In one aspect, the invention relates to compounds of formula I:
where X, Y, R
1
, R
2
, R
3
, R
4
, R
4
, and n are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin reuptake inhibitors. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
在一个方面,该发明涉及到以下式I的化合物:其中X、Y、R1、R2、R3、R4、R4和n如规范中定义,或其药用盐。式I的化合物是5-羟色胺再摄取抑制剂。在另一个方面,该发明涉及到包含这种化合物的药物组合物;使用这种化合物的方法;以及制备这种化合物的过程和中间体。